Latest Dana-Farber Cancer Institute Stories
Dana-Farber Cancer Institute scientists have successfully disrupted the function of a cancer gene involved in the formation of most human tumors by tampering with the gene's "on" switch and growth signals, rather than targeting the gene itself.
Scientists at Dana-Farber Cancer Institute and colleagues overseas have discovered a pair of backup circuits in cancer cells that enable the cells to dodge the effect of a widely used cancer drug.
In a joint study, scientists from The Scripps Research Institute and Harvard University's Dana-Farber Cancer Institute have established a new class of anti-diabetic compound that targets a unique molecular switch.
CANTON, Mass., Aug. 18, 2011 /PRNewswire/ -- Dunkin' Donuts is supporting the Dana-Farber Cancer Institute through the Jimmy Fund for the 13th year to help increase the chances of survival among cancer patients worldwide.
St. Jude Children's Research Hospital scientists lead research that settles a century-old debate about retinoblastoma's beginnings and identify new targets for treating the childhood eye tumor MEMPHIS, Tenn., Aug. 15, 2011 /PRNewswire-USNewswire/ -- A research team led by St.
SOUTH SAN FRANCISCO, Calif. and NORWALK, Conn., Aug. 3, 2011 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) and the Multiple Myeloma Research Foundation (MMRF) today announced the initiation of an expanded access program for carfilzomib, a selective, next-generation proteasome inhibitor.
Salk Institute and Dana Farber Cancer Institute researchers contribute to production of largest-ever map of plant protein interactions.
BOSTON, July 21, 2011 /PRNewswire/ -- Zipcar, Inc. (Nasdaq: ZIP), the world's leading car-sharing network, is taking on the 32nd annual Pan-Massachusetts Challenge (PMC) with a team of 25 riders and a goal of raising $150,000 to support cancer research and treatment.
Promising results of PI3K inhibitor study discussed at ASCO annual meeting SCOTTSDALE, Ariz., July 20, 2011 /PRNewswire-USNewswire/ -- A new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G.
Cancer biologists at MIT have identified a new lung cancer gene that drives the spread of the deadly condition.
- In medieval musical notation, a sign or neume denoting a shake or trill.